Short answer
Guardian Pharmacy Services, Inc. (GRDN) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $352M (up 2.2% year over year) with net income of $22M.
Q2 2026 key financials · XBRL
- Revenue
- $352M
- +2.2% YoY · +4.5% QoQ
- Net income
- $22M
- +142.2% YoY · +64.5% QoQ
- Operating margin
- 5.9%
- Gross margin
- 22.8%
Source: XBRL data from the Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 10-Q on SEC EDGAR. USD.
Guardian Pharmacy Services, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $351.8M, up 2.2% YoY from $344.3M; organic revenue decreased $5.9M from IRA pricing
- Net margin 6.3% vs 2.6%; Adjusted EBITDA margin 8.4% vs 7.2%
- Residents served increased to 210,000 from 195,000; prescriptions rose to 7.6M from 7.0M
- Cash $89.8M; operating cash flow $36.1M vs $37.5M YoY
- IRA price reductions expected to pressure year-over-year comparability throughout the remainder of 2026
Risk Factors
- No material changes to 10-K risk factors for year ended December 31, 2025
- No newly added risk factor triggered during quarter ended June 30, 2026
- Carried-forward investment risk: adverse developments could reduce Class A common stock market price
- Carried-forward investor risk: adverse developments could result in partial or total investment loss
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Guardian Pharmacy Services, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.